FA
WST icon

Faithward Advisors’s West Pharmaceutical WST Stock Holding History

Faithward Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-999
Closed -$275K – 340
2025
Q4 		$275K Sell
999
-10,856
-92% -$2.97M 0.04% 276
2025
Q3 		$3.11M Buy
11,855
+48
+0.4% +$11.7K 0.46% 69
2025
Q2 		$2.58M Buy
11,807
+1,316
+13% +$281K 0.4% 68
2025
Q1 		$2.35M Buy
10,491
+34
+0.3% +$9.37K 0.41% 71
2024
Q4 		$3.43M Buy
10,457
+510
+5% +$161K 0.58% 49
2024
Q3 		$2.99M Sell
9,947
-133
-1% -$40.7K 0.52% 58
2024
Q2 		$3.32M Buy
10,080
+170
+2% +$60.1K 0.6% 52
2024
Q1 		$3.92M Buy
9,910
+125
+1% +$46.2K 0.71% 42
2023
Q4 		$3.89M Buy
9,785
+516
+6% +$183K 0.86% 31
2023
Q3 		$3.13M Sell
9,269
-267
-3% -$103K 0.76% 38
2023
Q2 		$3.76M Sell
9,536
-272
-3% -$97.2K 0.87% 31
2023
Q1 		$3.53M Sell
9,808
-6,680
-41% -$1.95M 0.8% 29
2022
Q4 		$3.88M Buy
16,488
+3,896
+31% +$923K 0.84% 38
2022
Q3 		$3.1M Sell
12,592
-21
-0.2% -$6.4K 0.73% 45
2022
Q2 		$3.81M Buy
12,613
+444
+4% +$144K 0.86% 36
2022
Q1 		$5M Buy
12,169
+623
+5% +$244K 0.97% 33
2021
Q4 		$5.42M Sell
11,546
-1,484
-11% -$639K 1.03% 27
2021
Q3 		$5.53M Sell
13,030
-543
-4% -$229K 1.07% 24
2021
Q2 		$4.88M Buy
13,573
+2,695
+25% +$890K 0.97% 32
2021
Q1 		$3.07M Buy
+10,878
New +$3.11M 0.69% 40
2020
Q4 		– Sell
-12,924
Closed -$3.55M – 226
2020
Q3 		$3.55M Buy
+12,924
New +$3.42M 0.86% 41

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Faithward Advisors's WST Position: Q1 2026 in Review

Faithward Advisors sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 999 shares — an estimated $275K sold.

Faithward Advisors first reported a position in WST in Q3 2020 and held it in 21 quarters. The position peaked at $5.53M in Q3 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Faithward Advisors reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Faithward Advisors sold 999 West Pharmaceutical shares in Q1 2026, an estimated $275K.
  • Faithward Advisors first reported a position in West Pharmaceutical in Q3 2020 and held it in 21 quarters.
  • Faithward Advisors's West Pharmaceutical position peaked at $5.53M in Q3 2021.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Faithward Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.